For more details on the courses, please refer to the Course Catalog
| Code | Course Title | Credit | Learning Time | Division | Degree | Grade | Note | Language | Availability |
|---|---|---|---|---|---|---|---|---|---|
| PHR5152 | Receptology | 3 | 6 | Major | Master/Doctor | 1-4 | Pharmacy | Korean | Yes |
| Basic concepts on recept or theory, pharmacological and molecular biological knowledge related to recept or classification, recept or structure, and mechanisms and effects of recept or activation. | |||||||||
| PHR5155 | Neuropharmacology | 3 | 6 | Major | Master/Doctor | 1-4 | Pharmacy | Korean | Yes |
| Basic and advanced knowledge for the research on drugs which act on central and peripheral nervous system(mechanism of action, absorption, distribution, metabolism and drug-interaction). | |||||||||
| PHR5157 | Cardiovascular Pharmacology | 3 | 6 | Major | Master/Doctor | 1-4 | Pharmacy | - | No |
| Methods to measure the stability of pharmaceuticals are studied, including stability calculation for rate equations, interpretation of kinetic data for the degradation, degradation pathways for the drugs, solid-state chemical decomposition, methods of stabilization of pharmaceuticals, and strategy and tactics of stability testing. | |||||||||
| PHR5158 | Topics in Drug Interaction | 3 | 6 | Major | Master/Doctor | 1-4 | Pharmacy | Korean | Yes |
| Focus will be on basic principles of drug-drug interactions and its clinical applications. | |||||||||
| PHR5161 | Seminar in pharmacogenomics | 3 | 6 | Major | Master/Doctor | 1-4 | Pharmacy | Korean | Yes |
| Seminar on the recently published resarch papers dealing with pharmacogenetics and pharmacogenomics | |||||||||
| PHR5162 | Advanced Pharmacotherapeutics 1 | 3 | 6 | Major | Master/Doctor | 1-4 | Pharmacy | - | No |
| A subject dealing with pathophysiology of various disease states, pharmacotherapy including dosage calculations, adverse reactions, drug interactions, relevant pharmacokinetics, alternative therapies and monitoring parameters. The program will also involve the application of evidence based medicine to practise, identifying benefits and limitations to the population as a whole and the individual patient. | |||||||||
| PHR5163 | Advanced Pharmacotherapeutics 2 | 3 | 6 | Major | Master/Doctor | 1-4 | Pharmacy | - | No |
| A subject dealing with pathophysiology of various disease states, pharmacotherapy including dosage calculations, adverse reactions, drug interactions, relevant pharmacokinetics, alternative therapies and monitoring parameters. The program will also involve the application of evidence based medicine to practise, identifying benefits and limitations to the population as a whole and the individual patient. | |||||||||
| PHR5168 | Applied Pharmacology | 3 | 6 | Major | Master/Doctor | 1-4 | Pharmacy | - | No |
| This study will provide the understanding of pharmacological mechanism through studying recent scientific journals and reviews. Then student will get pharmacological knowledgeable to apply diseases and physiological phenomena. | |||||||||
| PHR5170 | Advanced Chemotherapeutics | 3 | 6 | Major | Master/Doctor | 1-4 | Pharmacy | - | No |
| A course intended to systemically understand and apply pharmacy students to the pharmacologic characteristics of antibacterial, antifungal, antiprotozoan, antivirus and antitumor agents. | |||||||||
| PHR5176 | Formuation of Nano-pharmaceuticals | 3 | 6 | Major | Master/Doctor | 1-4 | Pharmacy | - | No |
| Methods to formulate nano-pharmaceuticals including microemulsion, liposome and niosome are studied. | |||||||||
| PHR5177 | Formulation of Insoluble Drugs | 3 | 6 | Major | Master/Doctor | 1-4 | Pharmacy | - | No |
| The bio availability of water-insoluble drugs are usually very low. The methods to increase the solubility of these drugs and formulation methods are studied. | |||||||||
| PHR5178 | Formulation of Large-molecule | 3 | 6 | Major | Master/Doctor | 1-4 | Pharmacy | - | No |
| New therapeutic biomolecules are developed in the field of genomics. The stability, methods of administration, formulation of these large-molecules are studied. | |||||||||
| PHR5179 | Intelligent Drug Delivery System | 3 | 6 | Major | Master/Doctor | 1-4 | Pharmacy | - | No |
| The classification of various intelligent drug delivery systems, which are recently developed, and formulation methods, evaluation methods and preparation methods of each system are studied. | |||||||||
| PHR5180 | Transdermal Therapeutic System | 3 | 6 | Major | Master/Doctor | 1-4 | Pharmacy | - | No |
| To emphasize the kinds, formulation and production of therapeutic transdermal system. Validation of production and quality control procedures of therapeutic transdermal system are alsostudied. | |||||||||
| PHR5181 | Regulatory Toxicology | 3 | 6 | Major | Master/Doctor | 1-4 | Pharmacy | - | No |
| Regulatory covers regulations in the government and international societies. Based on risk assessment, risk management is the major part of regulatory toxicology. | |||||||||